What is a stock summary page? Click here for an overview.
Business Description
Elanco Animal Health Inc
NAICS : 325412
SIC : 2834
ISIN : US28414H1032
Compare
Compare
Traded in other countries / regions
ELAN.USAELAN.Mexico5EA.Germany Index Membership
Russell 1000Russell 3000 IPO Date
2018-09-20Description
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.71 | |||||
| Debt-to-EBITDA | 3.12 | |||||
| Interest Coverage | 1.07 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 0.99 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3 | |||||
| 3-Year EBITDA Growth Rate | 52.7 | |||||
| 3-Year EPS without NRI Growth Rate | 101.6 | |||||
| 3-Year FCF Growth Rate | 9.2 | |||||
| 3-Year Book Growth Rate | -8.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 7.25 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.17 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.06 | |||||
| 9-Day RSI | 43.38 | |||||
| 14-Day RSI | 43.07 | |||||
| 3-1 Month Momentum % | -9.93 | |||||
| 6-1 Month Momentum % | -21.67 | |||||
| 12-1 Month Momentum % | -32.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.44 | |||||
| Quick Ratio | 1.25 | |||||
| Cash Ratio | 0.36 | |||||
| Days Inventory | 298.49 | |||||
| Days Sales Outstanding | 73.58 | |||||
| Days Payable | 51.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | 17.41 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.88 | |||||
| Operating Margin % | 5.65 | |||||
| Net Margin % | 7.61 | |||||
| FCF Margin % | 8.56 | |||||
| ROE % | 5.48 | |||||
| ROA % | 2.48 | |||||
| ROIC % | 1.35 | |||||
| 3-Year ROIIC % | 2.33 | |||||
| ROC (Joel Greenblatt) % | 25.3 | |||||
| ROCE % | 5.87 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.82 | |||||
| Forward PE Ratio | 12.81 | |||||
| PE Ratio without NRI | 15.08 | |||||
| Price-to-Owner-Earnings | 5.36 | |||||
| PS Ratio | 1.2 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Free-Cash-Flow | 13.82 | |||||
| Price-to-Operating-Cash-Flow | 9.72 | |||||
| EV-to-EBIT | 12.52 | |||||
| EV-to-Forward-EBIT | 18.61 | |||||
| EV-to-EBITDA | 6.54 | |||||
| EV-to-Forward-EBITDA | 10.25 | |||||
| EV-to-Revenue | 2.04 | |||||
| EV-to-Forward-Revenue | 2 | |||||
| EV-to-FCF | 24.05 | |||||
| Price-to-GF-Value | 0.81 | |||||
| Price-to-Projected-FCF | 0.87 | |||||
| Earnings Yield (Greenblatt) % | 7.99 | |||||
| FCF Yield % | 7.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ELAN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Elanco Animal Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,439 | ||
| EPS (TTM) ($) | 0.67 | ||
| Beta | 1.96 | ||
| 3-Year Sharpe Ratio | -0.39 | ||
| 3-Year Sortino Ratio | -0.58 | ||
| Volatility % | 53.77 | ||
| 14-Day RSI | 43.07 | ||
| 14-Day ATR ($) | 0.399448 | ||
| 20-Day SMA ($) | 10.736 | ||
| 12-1 Month Momentum % | -32.75 | ||
| 52-Week Range ($) | 10.03 - 18.8 | ||
| Shares Outstanding (Mil) | 494.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Elanco Animal Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Elanco Animal Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Elanco Animal Health Inc Frequently Asked Questions
What is Elanco Animal Health Inc(ELAN)'s stock price today?
The current price of ELAN is $10.60. The 52 week high of ELAN is $18.80 and 52 week low is $10.03.
When is next earnings date of Elanco Animal Health Inc(ELAN)?
The next earnings date of Elanco Animal Health Inc(ELAN) is 2025-05-08 Est..
Does Elanco Animal Health Inc(ELAN) pay dividends? If so, how much?
Elanco Animal Health Inc(ELAN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers